Prescribed in‐hospital sodium intake for decompensated heart failure: A systematic review and meta‐analysis
Authors:
- 1 June 2025
- journal article
- review article
- Published by Wiley in Journal of Hospital Medicine
- Vol. 20 (11) , 1193-1201
Abstract
Background: Standard inpatient management of acute decompensated heart failure (ADHF) has included restricted dietary sodium. Sodium supplementation with diuretics has been proposed as an alternative to treat ADHF in an inpatient setting. Objectives: We conducted a systematic review to evaluate prescribed oral and/or intravenous sodium supplementation (with diuretics), to patients hospitalized for ADHF. Methods: We searched Medline, Embase, ClinicalTrials.gov , CINAHL, and Cochrane Database of Systematic Reviews from inception to September 24, 2024, for randomized controlled trials (RCTs), and nonrandomized comparative studies (NRCSs) reporting intermediate, clinical, or health service use outcomes for ADHF inpatients. We assessed risk of bias, and where there were at least three studies reporting results from similar analyses, we conducted meta‐analyses. GRADE methodology was used to assess the strength of evidence. Results: Fourteen RCTs and two NRCSs compared supplemental sodium with furosemide to furosemide alone. Supplemental sodium with furosemide significantly decreased serum creatinine (pooled net mean difference [NMD]: −0.33 mg/dL, 95% confidence interval [CI]: [−0.50 to −0.17]), brain natriuretic peptide (pooled NMD: −62.84 pg/mL, 95% CI: [−103.61 to −22.08]), and weight (pooled NMD: −2.48 kg, 95% CI: [−4.31 to −0.66]). There were no significant differences in N‐terminal pro b‐type natriuretic peptide (pooled NMD: −1614 pg/mL, 95% CI: [−3582 to 353]). There was a significant decrease in length of hospital stay (pooled MD: −2.68 days, 95% CI: [−3.81 to −1.55]). Studies provided insufficient evidence on mortality and readmission outcomes, and no evidence for caloric intake or clinical congestion score. Conclusions: Sodium supplementation with diuretics may improve kidney function, promote weight loss, and shorten length of hospital stay.Keywords
Funding Information
- U.S. Department of Veterans Affairs (ESP 22‐116)
This publication has 29 references indexed in Scilit:
- Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions – Part I: Loop DiureticsCurrent Heart Failure Reports, 2024
- Oral Sodium to Preserve Renal Efficiency in Acute Heart Failure: A Randomized, Placebo-Controlled, Double-Blind StudyJournal of Cardiac Failure, 2023
- Effects of Intravenous Furosemide Plus Small-Volume Hypertonic Saline Solutions on Markers of Heart FailureESC Heart Failure, 2021
- Efficiency of Hypertonic Saline in the Management of Decompensated Heart Failure: A Systematic Review and Meta-Analysis of Clinical StudiesAmerican Journal of Cardiovascular Drugs, 2020
- Comparison of three diuretic treatment strategies for patients with acute decompensated heart failureHerz, 2015
- Intravenous Salt Supplementation With Low-Dose Furosemide for Treatment of Acute Decompensated Heart FailureJournal of Cardiac Failure, 2014
- Hypertonic saline solution for prevention of renal dysfunction in patients with decompensated heart failureInternational Journal of Cardiology, 2013
- Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur)American Heart Journal, 2012
- Changes in Estimating Echocardiography Pulmonary Capillary Wedge Pressure After Hypersaline Plus Furosemide Versus Furosemide Alone in Decompensated Heart FailureJournal of Cardiac Failure, 2011
- The Effect of Dietary Sodium Restriction on Neurohumoral Activity and Renal Dopaminergic Response in Patients with Heart FailureEuropean Journal of Heart Failure, 2004